Wei Xiong

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Transforming Growth Factor

Inferior Vena Cava

Top Venues

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

The clinical respiratory journal

BMJ open respiratory research

Journal of thrombosis and thrombolysis

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Xiong, Yi Cheng, Yunfeng Zhao
Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Yunfeng Zhao, Yi Cheng, Yong Luo, Qihuan Yao, Jianmin Qu, Jinyuan Sun, Song Liu, Mei Xu, Wei Xiong
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Yunfeng Zhao, Yi Cheng, Qihuan Yao, Jianmin Qu, Yong Luo, He Du, Jinyuan Sun, Song Liu, Mei Xu, Xueling Wu, Wei Xiong
Optimal initial duration of low molecular weight heparin lead-in before direct oral anticoagulants for short-term outcomes of hospitalized patients with non-high-risk acute pulmonary embolism. QJM : monthly journal of the Association of Physicians (2024)
Wei Xiong, Yi Cheng, Yunfeng Zhao
Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Wei Xiong, Yugo Yamashita, Takeshi Morimoto, Toru Takase, Seiichi Hiramori, Kitae Kim, Maki Oi, Masaharu Akao, Yohei Kobayashi, Po-Min Chen, Koichiro Murata, Yoshiaki Tsuyuki, Yuji Nishimoto, Jiro Sakamoto, Kiyonori Togi, Hiroshi Mabuchi, Kensuke Takabayashi, Takao Kato, Koh Ono, Takeshi Kimura, null null
Initial hemodynamic status and Acute Mortality in Cancer patients with Acute Pulmonary Embolism: from the COMMAND VTE Registry. Journal of thrombosis and thrombolysis (2024)
Wei Xiong, Yi Cheng, Yunfeng Zhao
Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Yunfeng Zhao, Yi Cheng, Yong Luo, Qihuan Yao, Jianmin Qu, Jinyuan Sun, Song Liu, Mei Xu, Wei Xiong
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Yunfeng Zhao, Yi Cheng, Yong Luo, Qihuan Yao, Jianmin Qu, Jinyuan Sun, Song Liu, Mei Xu, Wei Xiong
International Normalized Ratio Predicts Recurrence and Bleeding in Patients With Acute Venous Thromboembolism Who Undergo Direct Oral Anticoagulants. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Wei Xiong, Xuejun Guo, He Du, Mei Xu, Yunfeng Zhao
Management of venous thromboembolism in patients with lung cancer: a state-of-the-art review. BMJ open respiratory research 10 (1) (2023)
Yunfeng Zhao, Yong Luo, Yi Cheng, Hongwei Wang, He Du, Jinyuan Sun, Mei Xu, Wei Xiong
Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary embolism who require secondary thromboprophylaxis. BMJ open respiratory research 10 (1) (2023)
Wei Xiong, Yunfeng Zhao, He Du, Yanmin Wang, Mei Xu, Xuejun Guo
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer. Thrombosis journal 19 (1) (2021)
Wei Xiong, Wei Ding, Mei Xu, Bigyan Pudasaini, Jinyuan Sun, Yunfeng Zhao
The screening role of a biomarker panel in BALF among patients with cancer-suspected pulmonary nodules less than 8 mm. The clinical respiratory journal 14 (9) (2020)
Wei Xiong, Yunfeng Zhao, Yifan Xiong, Mei Xu, Bigyan Pudasaini, He Du, Xuejun Guo
Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer. The clinical respiratory journal 14 (2) (2019)